Literature DB >> 23982852

SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013.

R Mesía1, M Pastor, J J Grau, E del Barco.   

Abstract

Nasopharyngeal carcinoma cases are not frequently encountered in our environment. Local stages are treated with radiotherapy. For advanced local stages, the association of chemotherapy with radiotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum-based chemotherapy and patients may achieve a long survival time.

Entities:  

Mesh：

Year:  2013        PMID： 23982852     DOI： 10.1007/s12094-013-1094-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  5 in total

1.  Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma.

Authors:  K K Fu
Journal:  Semin Radiat Oncol       Date:  1998-10       Impact factor: 5.934

2.  Influence of [18F] fluorodeoxyglucose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma.

Authors:  Xiao-Kang Zheng; Long-Hua Chen; Quan-Shi Wang; Fu-Bing Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-26       Impact factor: 7.038

3.  Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.

Authors:  Woo Kyun Bae; Jun Eul Hwang; Hyun Jeong Shim; Sang Hee Cho; Joon Kyoo Lee; Sang-Chul Lim; Woong-Ki Chung; Ik-Joo Chung
Journal:  Cancer Chemother Pharmacol       Date:  2010-02       Impact factor: 3.333

4.  The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition.

Authors:  K Shanmugaratnam; L H Sobin
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

Review 5.  Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma.

Authors:  B Baujat; H Audry; J Bourhis; A T C Chan; H Onat; D T T Chua; D L W Kwong; M Al-Sarraf; K H Chi; M Hareyama; S F Leung; K Thephamongkhol; J P Pignon
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18
  5 in total
  5 in total

1.  SEOM guidelines 2013: a response to the needs of Spanish oncologists.

Authors:  J J Cruz-Hernández; C A Rodríguez
Journal:  Clin Transl Oncol       Date:  2013-08-08       Impact factor: 3.405

2.  Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma.

Authors:  F Puebla; J L Lopez Guerra; J M Garcia Ramirez; R Matute; I Marrone; C Miguez; D Sevillano; A Sanchez-Reyes; E Rivin Del Campo; J M Praena-Fernandez; I Azinovic
Journal:  Clin Transl Oncol       Date:  2015-06-25       Impact factor: 3.405

3.  Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma.

Authors:  Yan Huang; Wenhua Liang; Yunpeng Yang; Liping Zhao; Hongyun Zhao; Xuan Wu; Yuanyuan Zhao; Yang Zhang; Li Zhang
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

4.  Apogossypolone induces apoptosis and autophagy in nasopharyngeal carcinoma cells in an in vitro and in vivo study.

Authors:  Ruinian Zheng; Kexu Chen; Yu Zhang; Jie Huang; Fengrong Shi; Gang Wu; Senming Wang
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

5.  Unusual presentation of nasopharyngeal carcinoma with rectal metastasis.

Authors:  Malvine Vogel; Hampig Raphael Kourie; Martine Piccart; Yassine Lalami
Journal:  World J Clin Cases       Date:  2017-05-16       Impact factor: 1.337
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.